Apyx Medical Corporation Prepares for Financial Results Release
Apyx Medical Corporation (NASDAQ: APYX) has announced the impending release of its third quarter fiscal year 2024 financial results. This announcement comes as the company continues to innovate within the medical technology sector. The results will be made publicly available before the market opens on November 8.
Details of the Financial Results Announcement
On the significant day of November 8, management will host a conference call at 8:00 a.m. Eastern Time. This conference call will allow stakeholders to gain insights into the financial performance of Apyx Medical for the quarter and will include a session for questions and answers. Interested participants can dial in to the call using 877-407-9039 or 201-689-8470 for international access and should reference access code 13749764. Specifically, participants should ask for the Apyx Medical Corporation Call to ensure they connect to the right session.
Accessing the Live Webcast
For those unable to join by phone, a live webcast of the conference call will be available. The webcast can be accessed via the company's official site in the Investor Relations section, providing an option to revisit the details in the future.
Apyx Medical’s Commitment to Innovation
Apyx Medical is known for its advanced energy technologies, particularly its proprietary helium plasma technology, marketed under the brand name Renuvion. This technology is transforming the landscape of both cosmetic surgery and hospital surgical markets. Renuvion, alongside J-Plasma, offers surgeons a unique tool for delivering controlled heat to tissues, allowing for precision in medical procedures.
Clinical Support and Product Effectiveness
The efficacy of Apyx Medical’s products is backed by a significant body of clinical research, with over 90 clinical documents supporting the use of Renuvion and J-Plasma. This clinical validation underscores the company’s dedication to enhancing surgical outcomes through innovative technology.
Investor Relations Contact Information
For any inquiries related to the financial announcement or company progress, Jeremy Feffer, Managing Director at LifeSci Advisors, can be reached at 212-915-2568. Jeremy remains a pivotal contact for investors looking to dive deeper into Apyx Medical’s financial health and strategic direction.
Overview of Apyx Medical Corporation
Apyx Medical Corporation stands at the forefront of advanced energy technology. Their mission is clear: to elevate the quality of life for individuals through innovative medical products. The company continues to make strides in both the cosmetic and surgical arenas, leveraging its deep expertise in unique waveforms through partnership agreements with other medical device manufacturers.
For more details regarding Apyx Medical and its innovative offerings, the company invites interested parties to explore their official website, which is regularly updated with the latest information.
Frequently Asked Questions
When will Apyx Medical report its third quarter financial results?
Apyx Medical will release its third quarter financial results on November 8, 2024, before the market opens.
How can I participate in the conference call?
To join the conference call, you can dial in at 877-407-9039 or 201-689-8470 for international calls. Use access code 13749764.
Will there be a webcast available for the conference call?
Yes, a live webcast will be available on the company’s website in the Investor Relations section for those who prefer to listen online.
What technologies does Apyx Medical focus on?
Apyx Medical specializes in advanced energy technologies, particularly in helium plasma technology, which is used in cosmetic and surgical procedures.
How can I contact Apyx Medical’s investor relations?
You can reach out to Jeremy Feffer, Managing Director at LifeSci Advisors, at 212-915-2568 for investor inquiries.
